Psoriasis Could Be Behind Frequent Fatigue Psoriasis is

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
213
Psoriasis Could Be Behind Frequent Fatigue

Psoriasis is a topical condition that causes dry, scaly and itchy patches to develop on the skin around the scalp, trunk, elbows and knees. The condition is chronic and is typically managed using medication to alleviate symptoms, coping strategies and different lifestyle habits to minimize the number of triggers in your life. Even though psoriasis typically acts on the skin, with its symptoms generally affecting different areas of the skin, studies have found that psoriasis may also cause exhaustion.

Exhaustion is something we all experience every day. It is a normal part of the human experience that is essentially the body’s way of telling you to take a break, rest and recharge. Chronic exhaustion, on the other hand, is often caused by underlying medical conditions and typically affects women more than men.

In some cases, the underlying condition causing chronic pain may be psoriasis.

The American Academy of Dermatology Association (AAD) explains that some people with psoriasis may be dealing with persistent fatigue that affects their day-to-day activities. A 2023 study published in the “British Journal of Dermatology” estimates that some 30% of the 4 million Americans living with psoriasis regularly experience fatigue.

Some estimates suggest that up to 50% of Americans with psoriasis may experience persistent fatigue.

A different analysis of psoriasis patients in the United States, which was published in the “Journal of the American Academy of Dermatology” last December, found that one in three psoriasis patients experienced “severe fatigue.” Furthermore, patients who developed psoriatic arthritis were much more likely to experience severe exhaustion.

American Academy of Dermatology fellow and board-certified dermatologist Roslyn George, MD, notes that although most people think psoriasis just affects the skin, psoriasis is actually a systematic disease that affects the whole body.

While physicians still don’t understand why psoriasis leads to chronic fatigue, they believe that this may be due to the disease’s interaction with the immune system. The theory is that since psoriasis is an inflammatory condition, it puts the entire immune system on “hyper alert” all the time and forces the body to spend a significant amount of energy keeping the immune system active.

Boston Medical Center dermatologist and Boston University School of Medicine associate professor of dermatology Neelam Vashi, MD, notes that the inflammation caused by psoriasis can go to the joints, skin and other body parts, and consumes the body’s energy.

According to Southern Illinois University School of Medicine emeritus professor of dermatology Stephen P. Stone, MD, the discomfort caused by psoriasis can also make it difficult for patients to sleep. By disrupting sleep patterns, psoriasis makes it difficult for patients to enjoy a full night’s sleep, increasing their risk of developing fatigue buildup over the long-term.

However, there is hope for patients. Numerous companies, such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), are working to commercialize novel treatments such as immunotherapies that can offer better clinical outcomes to patients.

NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer


BiondVax Pharmaceuticals Ltd. (BVXV) Stock Research Links

BVXV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 37

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 28

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 32

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 36

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 23

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 36

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Technologies Unveiled by LG Innotek at CES 2025

Updated Category News Views 383

Innovative Showcase by LG Innotek at CES 2025 LG Innotek has exciting plans for CES 2025, showcasing its commitment to revolutionizing future mobility. This year, the company aims to highlight its advanced technologies at a well-organized exhibition booth set within the bustling West Hall. A Focus on Future Mobility Technologies At CES 2025, LG Innotek will present a...

Continue Reading
Alumis and ACELYRIN Merger: A New Era for Biopharma Innovation

Updated Category News Views 277

Alumis and ACELYRIN Merge to Forge a New Path in Biopharma The biopharmaceutical landscape is about to witness a significant transformation as Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. (NASDAQ: SLRN) announce their merger. This strategic alliance aims to innovate, develop, and commercialize new therapies for immune-mediated diseases. With top-tier clinical programs...

Continue Reading
Legal Reminder for ICON Shareholders: Act Before Deadline

Updated Category News Views 147

Important Update for ICON plc Shareholders In a significant legal development, shareholders of ICON plc need to be aware of a class action lawsuit that has implications for their investments. If you have incurred losses exceeding $100,000, it is essential to act swiftly, as the deadline for filing lead plaintiff applications is approaching. This lawsuit originates from...

Continue Reading
Corvus Pharmaceuticals to Showcase Innovations at Investment Event

Updated Category News Views 50

Corvus Pharmaceuticals to Present at Major Investment Conference BURLINGAME, Calif. — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a prominent name in the clinical-stage biopharmaceutical sector, is thrilled to announce that its president and CEO, Richard A. Miller, M.D., along with Jeffrey Arcara, the chief business officer, will be participating in one-on-one meetings...

Continue Reading
Discover Promising Dividend Stocks with Robust Growth Potential

Updated Category News Views 122

Exploring Reliable Dividend Stocks with Growth Potential Investors have found that dividend stocks generally offer a compelling annual return averaging 9.2% since 1973, showing less volatility than the broader market index. These investments can provide a steady income stream while also having a significant upside potential. In this article, we delve into three stocks...

Continue Reading